Back

Chronic obstructive pulmonary disease and implantable cardioverter-defibrillator in non-ischemic heart failure with reduced ejection fraction: extended follow-up of the DANISH trial

31 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Heart failure management in specific populations Implantable Cardioverter-Defibrillator (ICD) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Adelina Yafasova

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

9 More presentations in this session

Presentation thumbnail
Efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population
Doctor J. Noiri (Kobe, JP)
Abstract Slides Video
Presentation thumbnail
Phenotypes of heart failure with preserved ejection fraction and effect of sodium-glucose cotransporter 2 inhibitors treatment
Doctor A. Sezaki (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
The relevant role of frailty in patients with transthyretin amyloidosis cardiomyopathy
Doctor B. Dal Passo (Ferrara, IT)
Abstract Slides Video
Presentation thumbnail
Role of comorbidities and weight variations in the survival of diabetic patients with heart failure
Professor O. Hanon (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Angiotensin receptor-neprilysin inhibitor-based therapy among adult heart failure patients with below normal systemic ventricular ejection fraction and complex congenital heart disease
Doctor D. Dela Cruz (Metro Manila, PH)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure management in specific populations

The Event

Event poster

ESC Congress 2025

31 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
New york heart association functional class does not modify the effect of an implantable cardioverter-defibrillator in nonischemic heart failure with reduced ejection fraction: a DANISH substudy
thumbnail
Congress Presentation
Atrial fibrillation/flutter may modify the long-term effect of primary prevention implantable cardioverter-defibrillators in non-ischemic HFrEF: an extended follow-up study of the DANISH trial
thumbnail
Congress Presentation
Increased diagnostic testing and higher cardiovascular risk in patients with chronic obstructive pulmonary disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources